0001250853-13-000072.txt : 20130502
0001250853-13-000072.hdr.sgml : 20130502
20130502185725
ACCESSION NUMBER: 0001250853-13-000072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130430
FILED AS OF DATE: 20130502
DATE AS OF CHANGE: 20130502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1500 WEST PARK DRIVE
STREET 2: SUITE 210
CITY: WESTBOROUGH
STATE: MA
ZIP: 01581
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 1500 WEST PARK DRIVE
STREET 2: SUITE 210
CITY: WESTBOROUGH
STATE: MA
ZIP: 01581
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galena Biopharma, Inc.
CENTRAL INDEX KEY: 0001390478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54910
FILM NUMBER: 13809704
BUSINESS ADDRESS:
STREET 1: 310 N. STATE STREET
STREET 2: SUITE 208
CITY: LAKE OSWEGO
STATE: OR
ZIP: 97034
BUSINESS PHONE: 855 855 GALE
MAIL ADDRESS:
STREET 1: 310 N. STATE STREET
STREET 2: SUITE 208
CITY: LAKE OSWEGO
STATE: OR
ZIP: 97034
FORMER NAME:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20110926
FORMER NAME:
FORMER CONFORMED NAME: GALENA BIOPHARMA, INC.
DATE OF NAME CHANGE: 20110922
FORMER NAME:
FORMER CONFORMED NAME: RXI PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20110921
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-04-30
1
0001533040
RXi Pharmaceuticals Corp
RXII
0001390478
Galena Biopharma, Inc.
310 N. STATE STREET
SUITE 208
LAKE OSWEGO
OR
97034
0
0
1
0
Common Stock, $0.0001 par value
2013-04-30
4
S
0
171000
0.2138
D
33305595
D
Common Stock, $0.0001 par value
2013-05-01
4
S
0
659500
0.1925
D
32646095
D
Common Stock, $0.0001 par value
2013-05-02
4
S
0
253000
0.1905
D
32393095
D
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.21 to $0.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.19 to $0.21, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.19 to $0.1905, inclusive.
Galena Biopharma, Inc., By: /s/ Ryan M. Dunlap, Director of Finance, Controller
2013-05-02